Hypogonadism in Men Consuming Sustained-Action Opioids

2002, Harry W. Daniell Conclusions: Commonly prescribed opioids in sustained-action dosage forms usually produce subnormal sex hormone levels, which may contribute to a diminished quality of life for many patients with painful chronic illness. Read here Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. J Pain. 2002 Oct;3(5):377-84. doi: 10.1054/jpai.2002.126790. PMID: 14622741.

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

Conclusions: Based on total testosterone (TT) concentration, the prevalence of hypogonadism in men reporting to primary care offices was estimated to be 38.7%. The medical conditions that occurred significantly more frequently among hypogonadal men than eugonadal men included increased BMI, hypertension, hyperlipidaemia, diabetes, and asthma or COPD. As men age, they are susceptible to conditions …

Dr. Elizabeth Lee Vliet, MD speaks on the Women’s Health Initiative (WHI) Study

April 2009 by Dr. Elizabeth Lee Vliet, MD The Women’s Health Initiative was a series of clinical studies initiated by the U.S. National Institutes of Health in 1991, to address major health issues causing morbidity and mortality in postmenopausal women. It consisted of three clinical trials and an observational study. In particular, randomized controlled trials …

Truth for Health Foundation Statement on the Baylor-Scott & White lawsuit against Dr. Peter A. McCullough, the Foundation’s Chief Medical Advisor:

Attempting to silence the Chief Medical Advisor of a public charity foundation by retaliatory and intimidating lawsuits for speaking to the public directly interferes with and threatens the core MISSION of OUR PUBLIC CHARITY which has a duty to serve the public good with truthful medical information. As President of the Foundation, I have a …